Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO


Posted in: Drug Trial News | Medical Condition News

Tags: Acute Coronary Syndrome, Angina, Anticoagulant, Anti-Inflammatory, Aspirin, Atherosclerosis, Atrial Fibrillation, Back Pain, Blood, Blood Clot, Blood Clots, Brain, Breast Milk, Breastfeeding, Catheter, Catheter Ablation, Clinical Trial, Clopidogrel, Coronary Artery Disease, Coronary Heart Disease, Cough, Deep Vein Thrombosis, Drugs, Epidural, Health Care, Healthcare, Heart Attack, Heart Disease, Heart Failure, Heart Rate, Heparin, Hip Replacement, Hospital, Immunology, Incontinence, Infectious Diseases, Ischemic Stroke, Knee Replacement, Lopinavir, Medicare, Muscle, Neuroscience, Oncology, Pain, Paralysis, Peripheral Artery Disease, Plavix, Pregnancy, Pulmonary Embolism, Ritonavir, Rivaroxaban, Spine, Stent, Stroke, Thrombosis, Vaccines, Venous Thromboembolism, Vitamin, Vitamin K, Warfarin